Abstract: Leishmania major (L. major) is a protozoan parasite that causes cutaneous leishmaniasis. About 12 million people are currently infected with an annual incidence of 1.3 million cases. The purpose of this study was to synthesize a small library of novel thiophene derivatives, and evaluate its parasitic activity, and potential mechanism of action (MOA). We developed a structure-activity relationship (SAR) study of the thiophene molecule 5A. Overall, eight thiophene derivatives of 5A were synthesized and purified by silica gel column chromatography. Of these eight analogs, the molecule 5D showed the highest in vitro activity against Leishmania major promastigotes (EC 50 0.09 ± 0.02 µM), with an inhibition of the proliferation of intracellular amastigotes higher than 75% at only 0.63 µM and an excellent selective index. Moreover, the effect of 5D on L. major promastigotes was associated with generation of reactive oxygen species (ROS), and in silico docking studies suggested that 5D may play a role in inhibiting trypanothione reductase. In summary, the combined SAR study and the in vitro evaluation of 5A derivatives allowed the identification of the novel molecule 5D, which exhibited potent in vitro anti-leishmanial activity resulting in ROS production leading to cell death with no significant cytotoxicity towards mammalian cells.
Introduction
Leishmaniasis is a devastating neglected tropical disease (NTD) [1] caused by the protozoan parasite of the genus Leishmania. The parasite is transmitted from animals to humans through the bite of infected females Lutzomyia or Phlebotomus sand flies [2] . Over 20 species and subspecies of Leishmania infect humans, causing three major clinical forms of the disease: cutaneous (CL), visceral, and mucocutaneous leishmaniasis [3] . The prevalence of CL, the most common form of leishmaniasis, is estimated between 0.7 and 1.3 million new annually cases worldwide [4] , and it is commonly caused by Leishmania major (L. major) or L. mexicana. CL presents as singular ulcerative or nodular lesions at the 
Efficacy and Cytotoxicity of Parent Compound 5A
First, the efficacy of thiophene derivative 5A was evaluated against transgenic L. major promastigotes expressing firefly luciferase (L. major-luc) as previously described [16, 17] . Compound 5A at a range of 0.31-10 µM was incubated with 2 × 10 6 L. major-luc promastigotes per mL for 72 h at 28 • C, and in vitro parasite viability (% survival) was measured by luciferase activity. Compound 5A displayed an approximate 50% effective concentration (EC 50 ) of 0.34 µM against L. major promastigotes ( Figure 3 and Table 1 ). Furthermore, we investigated the potential cytotoxicity of 5A by alamarBlue™ Cell Viability Assay (Thermo Fisher Scientific, Waltham, MA, USA) [18] and 5A displayed a selective index (S.I.) of 30.58 against BALB/c intraperitoneal mouse macrophages (IPΦ), and 51.91 in monkey kidney cells (LLC-MK2) ( Table 1) . 
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5A
amp B 1% DMSO Consequently, to lower the toxicity and increase the parasitic activity, eight new thiophene molecules ( Figure 2 ) were evaluated. First, the thiophene compounds were tested in the presence of increasing drug concentrations (1.56-12.5 µM), followed by incubation with L. major-luc promastigotes (2 × 10 6 /mL) for 72 h at 28 • C. The experiment was performed using the same conditions as described for the parent drug 5A. As summarized in Table 1 , all eight thiophene molecules showed promising antileishmanial activity against L. major promastigotes with an EC 50 ranging from 0.09 to 6.25 µM ( Figure 4A ). However, the best thiophene compounds were 5D (EC 50 0.09 ± 0.02 µM) and 5E (EC 50 0.78 ± 0.11 µM) ( Figure 4B and Table 1) .
Consequently, cytotoxicity assays were performed by incubating LLC-MK2 or IPΦ with compounds. First, 5D or 5E were incubated with 1 × 10 5 LLC-MK2/mL or 1 × 10 5 IPΦ/mL for 72 and 48 h, respectively. Interestingly, compound 5D did not display perceptible toxicity against LLC-MK2 at concentrations up to 80 µM ( Figure 4C,D 
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Consequently, cytotoxicity assays were performed by incubating LLC-MK2 or IPФ with compounds. First, 5D or 5E were incubated with 1 × 10 5 LLC-MK2/mL or 1 × 10 5 IPФ/mL for 72 and 48 h, respectively. Interestingly, compound 5D did not display perceptible toxicity against LLC-MK2 at concentrations up to 80 µM ( Figure 4C,D) . In the case of IPФ, 5D exhibited a CC50 value of 27.89 ± 3.19 µM and an excellent S.I. of 310. As 5E compound CC50 values of 80 ± 4.45 µM in LLC-MK2 cells and 16.59 ± 1.52 µM in IPФ, with S.I. values of 102.56 and 21.27, respectively. More importantly, we determined that both 5D and 5E displayed lower cytotoxicity to mammalian cells and higher parasitic activity than parent compound 5A (Table 1 ). 
In Vitro Efficacy of Thiophene 5D Against Intracellular Amastigotes
Additionally, efficacy of thiophene compounds 5D and 5E was tested against the infectious intracellular amastigote form of L. major, by High-Content Imaging Assay (HCIA) on infected intraperitoneal mouse macrophages. As observed in Figure 5A , in comparison with untreated control and 1% DMSO, 5D and 5E inhibited the proliferation of the intracellular amastigotes by more than 75% and 50%, respectively, at a 0.625 µM concentration. Furthermore, as observed in Figure 5B , a reduced number of infected cells were observed after 5D or 5E treatment (2.5 µM) when compared to control treated with 1% DMSO.
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Molecule 5D Induces ROS in L. major
Based on our previous study [12] , it was hypothesized that 5D may induce parasite death through the production of ROS. Thus, 2 × 10 6 L. major promastigotes per mL were incubated with 5D (EC50 0.09 ± 0.02 µM). After 24 h, ROS levels were measured by the addition of 10 µM of the cellpermeable dye H2DCFDA (Thermo Fisher Scientific, Waltham, MA, USA), and fluorescence was monitor for an additional 7 h using a fluorometer. As expected, ROS levels in 5D treated parasites were 14.5-fold higher compared to vehicle control 1% DMSO ( Figure 6 ). 
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Docking of 5D on TryR from Leishmania
Next, to determine the possible molecular mechanism responsible for the antileishmanial activity of 5D, docking studies on TryR from L. infantum (PDB id: 2JK6) were performed. Using Glide Standard Precision [19] and Extra Precision (XP), we performed Rigid Receptor Docking analysis of control (Quinacrine Mustard) and 5D. The 3D ligand structures were docked against the best potential binding site of 2JK6. Glide SP and XP only accounts for the ligand being dynamic however the protein remains rigid. Docking box coordinates and dimensions remained all at default (20 × 20 × 20 Å). Glide XP gives an output of a docking score, which was analyzed by the lowest number, or whichever is more negative to be the highest scoring ligand. The docking results, summarized in Table 2 , showed the control (Quinacrine Mustard) with higher binding affinity than 5D in both SP and XP. However, the XP docking score did not differ by much, indicating more rigorous docking analysis is needed. Thus, both ligands were taken to Schrodinger's Flexible receptor docking. Schrodinger IFD protocol for all IFD jobs was used [20] . The IFD program makes use of both Glide (for docking) and Prime (for protein structure modeling). The combination of the two software packages allows a more accurate ligand binding calculation. We performed the re-docking with Glide 
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Discussion
There is an urgent need for new therapeutics that are more effective and less toxic than conventional treatments used to treat infectious diseases, including leishmaniasis [25] . Thiophenes derivatives are known for their therapeutic applications and have shown promising results to treat different types of cancer, degenerative diseases, HIV, and malaria [26] [27] [28] [29] [30] [31] [32] [33] . Thus, we evaluated the anti-leishmania activity and selectivity of nine thiophene derivatives against L. major, and potential MOA was elucidated for our best candidate, 5D.
Thiophene derivatives 5A, 5D and 5E exhibited potent parasitic activity against L. major promastigotes (Table 1 ). Experimental models involving macrophages are ideal to study leishmaniasis since they are the major host cell for Leishmania spp. [34] . Thus, our three best candidates were further evaluated against the most important form of the parasite, intracellular 
Thiophene derivatives 5A, 5D and 5E exhibited potent parasitic activity against L. major promastigotes (Table 1) . Experimental models involving macrophages are ideal to study leishmaniasis since they are the major host cell for Leishmania spp. [34] . Thus, our three best candidates were further evaluated against the most important form of the parasite, intracellular amastigotes, in an in vitro infection model of murine macrophages. In this case, 5D presented the best anti-leishmanial activity by decreasing the proliferation of the parasite by 80%.
The in vitro toxicity of 5D and 5E was evaluated towards IPΦ and LCC-MK2 cells. Our best two compounds were safer for the two cytotoxic models than the reference drug, amphotericin B, which is already known for its cytotoxic effects [35] . Even though amphotericin B presented similar activity as 5D against promastigotes and amastigotes, this result further supports the application of 5D and 5E as anti-leishmanial agents. Furthermore, the selectivity presented by 5D was remarkably higher than the parent compound 5A (10-fold higher), demonstrating the success to increase the anti-leishmanial activity and reduced cytotoxicity effects when compared to our previously reported arylalkylamine type-compound [12] .
Next, we studied the potential MOA of derivative 5D. ROS can be generated in response to some drugs, resulting in destruction of cellular macromolecular components inducing cell death by affecting parasite mitochondrial function [36, 37] . Here, we observed that 5D induced ROS production in L. major promastigotes after 31 h of treatment. The redox homeostasis in Leishmania is achieved through the activity of several superoxide dismutases, heme peroxidases, as well as of a series of thiol-containing proteins that directly or indirectly depend on trypanothione reductase [23, 38] . In this regard, the trypanothione metabolism is unique to trypanosomatids and its main detoxification pathway [39] . This pathway protects parasites from oxidative stress and participates in several cellular processes that are carried out by glutathione in other organisms. Moreover, there are several trypanothione-dependent pathways that include enzymes such as tryparedoxin peroxidase (detoxication of hydroperoxide), ascorbate peroxidase (homeostasis of ascorbate), ribonucleotide reductase (synthesis of DNA precursors), and others [40, 41] . With this idea on mind, we decided to explore in silico docking analysis to assess the possibility of L. major TryR as the target of 5D. Moreover, our results suggested that TryR interacts with 5D, however we do not exclude the possibility that other redox metabolism enzymes could be also targeted by compound.
In conclusion, to discover new chemotherapy agents against leishmaniasis, we efficiently synthetized nine thiophene type-compounds including 5A, following a two-step synthesis from low-priced commercially available starting materials. We then showed that our novel thiophene type-compounds possess high in vitro antileishmanial activity. Based on our SAR study, 5D analog was selected as the most promising lead compound among this library with excellent antiparasitic and S.I. Furthermore, 5D may act against trypanothione metabolism, followed by the production of ROS in the parasite; nevertheless, biological studies with recombinant TryR enzyme needs to be performed to further support this assumption. Overall, 5D represents a potential chemotherapeutic agent for the treatment of leishmaniasis, and further evaluation in a pre-clinical mouse model of cutaneous leishmaniasis is currently in progress in our laboratory.
Materials and Methods
General
Unless otherwise noted, all commercial reagents were used as purchased from Aldrich, St. Louis, MO, USA. All the reactions were monitored by thin-layer chromatography (TLC) that was performed on silica gel plates GF254. Compounds were visualized under a UV lamp. Flash chromatography was performed using silica gel (200-300 mesh) with various ratios of Dichloromethane: Methanol solvents as indicated in the text. Spectroscopy: 1 H and 13 C-NMR spectra were obtained on a Bruker DPX 400 MHz. Chemical shifts (δ) are quoted in parts per million (ppm), to the nearest 0.01 ppm and internally referenced relative to the solvent nuclei. 1 H-NMR spectral data are reported with their chemical shift in parts per million (ppm). The multiplicity in 1 H-NMR is abbreviated as follows: brs: broad; s: singlet; d: doublet; t: triplet; q: quartet; quint: quintet; sext: sextet; m: multiplet; or as a combination (e.g., dd, dt, etc.). The coupling constant (J) in hertz, integration and proton count were determined.
Spectrometer: Liquid chromatography/mass spectra (LC-MS) [+ESI] were taken on double focusing sector type mass spectrometer HX-110A. Maker JEOL Ltd. Tokyo, Japan (resolution of 10,000 and 10 KV accel. Volt. Ionization method; FAB (Fast Atom Bombardment) used Xe 3 KV energy. Used Matrix, NBA (m-Nitro benzyl alcohol)). Melting points were measured using a Mel-Temp melting point apparatus.
Chemical Synthesis
General Synthetic Procedure 1
Synthesis of the Ethyl 5,5,7,7-tetramethyl-2-(4-(trifluoromethyl) benzamido)-4,5,6,7-tetrahydrothieno [2,3-c]pyridine-3-carboxylate (5A) Briefly, the 2,2,6,6-tetramethylpiperidine ketone (1, 1 equivalent) was mixed with 2-cyanoacetate esters (2, 1 equivalent) and elemental sulfur (1 equivalent) in the presence of diethylamine (3 equivalents) in ethanol (ETOH) at 60 • C for 17 h. The crude was precipitated by adding water and filtered to provide the desired known 2-aminothiophene intermediate (3) [12] . The latter was reacted with 4-trifluomethy benzoyl chloride in the presence of diisopropylethylamine in dry dichloromethane at 0 • C for 1 h and then at room temperature for 4 h. The solvent was evaporated then the crude mixture was purified by flash-column chromatography on silica gel, using a mixture of solvent of dichloromethane: methanol (DCM: MeOH) at ratios from 100:1 to 50:1, to provide the desired ethyl 5,5,7,7-tetramethyl-2-(4-(trifluoromethyl)benzamido)-4,5,6,7-tetrahydrothieno [2,3-c]pyridine-3-carboxylate (5A) as a light brown solid. The purity of 5A was confirmed by 1 H-NMR, 13 C-NMR, LC/MS and melting point.
General Synthetic Procedure 2
Synthesis of 5,5,7,7-tetramethyl-2-(2-(trifluoromethyl)benzamido)-4,5,6,7-tetrahydrothieno [2,3-c]pyridine-3-carboxylic acid (5G) To ethyl 5,5,7,7-tetramethyl-2-(2-(trifluoromethyl)benzamido)-4,5,6,7-tetrahydrothieno [2,3-c] pyridine-3-carboxylate compound (5B; 1 equiv.) in 1 mL of tetrahydrofuran (THF), was added 5 equiv. of sodium hydroxide (NaOH) in water (1 mL). The mixture was stirred at room temperature during 17 h. The THF solvent was evaporated then mixture was acidified with HCl 1M to pH = 4. The protonated acid compound was extracted with ethylacetate (EtOAc) (3×; 50 mL) then dried under magnesium sulfate (MgSO 4 ), and the solvent was evaporated to provide the desired 5,5,7,7-tetramethyl-2-(2-(trifluoromethyl)benzamido)-4,5,6,7-tetrahydrothieno [2,3-c]pyridine-3-carboxylic acid (5G), (Figure 2 ). The purity of 5G analog was confirmed by 1 H-NMR, 13 C-NMR, and LC/MS.
Following the general synthetic procedure 1, and in the presence of various substituted benzoyl chlorides, we created the analogs 5B-5E, and 5H-5I.
Ethyl-5,5,7,7-tetramethyl-2-(2-(trifluoromethyl)benzamido)-4,5,6,7-tetrahydrothieno [2,3-c] 
Cell Maintenance
Transgenic L. major promastigotes expressing firefly luciferase (L. major-luc) (Lmj-FV1-LUC-TK [L. major strain Friedlin {MHOM/JL/80/Friedlin}] were maintain in M199 medium supplemented with hemin, 10% inactivated fetal bovine serum (iFBS) (Gibco, Thermo Fisher Scientific, Waltham, MA, USA), and 1% of 10,000 units/mL penicillin and 10 mg/mL streptomycin (Gibco, Thermo Fisher Scientific, Waltham, MA, USA) as described [42] . Intraperitoneal murine macrophages (IPΦ) were obtained from BALB/c mice [43] . Monkey kidney epithelial cells (LLC-MK2) (ATCC # CCL-7) (American Type Culture Collection, Manassas, VA, USA), and IPΦ were cultured in Dulbecco's Modified Eagle's Medium (DMEM), supplemented with 10% iFBS, along with 1% of 10,000 units/mL penicillin and 10 mg/mL streptomycin. The procedures were performed minimizing the distress and pain for animals following the NIH guidance and animal protocol (A-201107-1) approved by UTEP's Institutional Animal Care and Use Committee (IACUC).
Luciferase Assay-Viability of Leishmania Major promastigotes
The antiparasitic activity of the 9 thiophene compounds was determined by adding the analogs together with 2 × 10 6 L. major-luc promastigotes per mL in 96-well NUNC white microplates (Thermo Fisher Scientific, Waltham, MA, USA) followed by incubation for 72 h at 28 • C. Then, parasite survival was measured by luciferase activity with the addition of the substrate 5 -fluoroluciferin (ONE-Glo luciferase assay system; Promega, Madison, WI, USA), using a luminometer (Luminoskan; Thermo Fisher Scientific, Waltham, MA, USA). The luminescence intensity was a direct measure of the parasite survival, and 50% effective concentration (EC 50 ) was determined for each drug and summarized in Table 1 .
Assessment of Thiophene Compound Mammalian Cell Cytotoxicity
The potential cytotoxicity of 5A was tested by alamarBlue TM Cell Viability Assay (Thermo Fisher Scientific, Waltham, MA, USA) as previously described [18] . Briefly, 1 × 10 6 /mL rhesus monkey kidney epithelial cells (LLC-MK2), and 1 × 10 6 /mL BALB/c IPΦ were seeded in a 96-well clear bottom black microplate (BD Biosciences, Franklin Lakes, NJ, USA). Cells were incubated in the presence of increasing drug concentrations for 72 h (LLC-MK2) or 48 h (IPΦ) at 37 • C, 5% CO 2 , followed by addition of alamarBlue TM . Fluorescence was measured using a fluorometer (Fluoroskan; Thermo Fisher Scientific, Waltham, MA, USA). Compound 5D or 5E were incubated with 1 × 10 5 cells/mL (LLC-MK and IPΦ) for 72 or 48 h, respectively, at 37 • C, 5% CO 2 . After the incubation period, a dilution of 20:1000 in PBS from a stock at 1 mg/mL of Propidium Iodide (PI) and Hoechst 33342 (Thermo Scientific, Waltham, MA, USA) were added for survival discrimination as previously described [44] . Analysis was performed by High-Content Imaging Assay (HCIA) using an IN Cell 2000 Analyzer Bioimaging System (GE Healthcare, Chicago, IL, USA) for LLC-MK2 cells, and BD Pathway 855 High-resolution Bioimager System (BD Biosciences, Franklin Lakes, NJ, USA) for IPΦ. The 50% cytotoxic concentration (CC 50 ) and selective index (S.I.) was determined and summarized in Table 1 .
High-Content Imaging Assay-Proliferation Experiments
BALB/c IPΦ were acquired and seeded at a density of 1 × 10 5 cells/mL for 2 h at 37 • C, 5% CO 2 . After adherence, IPΦ were infected with 1 × 10 6 /mL metacyclic promastigotes of L. major-luc, at a ratio of 10:1 parasites per macrophage. Subsequently, infected IPΦ were incubated with derivatives 5A, 5D and 5E at increasing concentrations (0.625 to 10 µM) for 48 h treatment. Afterwards, cells were fixed with 4% paraformaldehyde, and stained with (1.25:100) Alexa Fluor™ 488 Phalloidin (Thermo Fisher Scientific, Waltham, MA, USA) and (1:1000) DAPI (Sigma Aldrich, St. Louis, MO, USA). Then, the numbers of infected cells and amastigotes were determined by HCIA using an IN Cell 2000 Analyzer Bioimaging System (GE Healthcare, Chicago, IL, USA). Parameters were set for the excitation and emission spectra of Alexa Fluor™ 488 Phalloidin and DAPI, and a constraint of 3 or more parasites per macrophage was set as previously reported [44, 45] .
Measurement of Reactive Oxygen Species Levels
L. major promastigotes (2 × 10 6 cells/mL) were incubated for 24 h with 5D (EC 50 0.90 µM) in a 96-well clear bottom black microplate (BD Biosciences, Franklin Lakes, NJ, USA). Controls treated with 1% DMSO, 100 µM of hydrogen peroxide (H 2 O 2 ) as positive control, or M199 medium. After incubation period, 10 µM of H 2 DCFDA (Thermo Fischer Scientific, Waltham, MA, USA) (H 2 DCFDA/DMSO, 1 mg/mL) was added per well followed by 20 min of incubation at 37 • C. Fluorescence was measured for an additional 7 h using a fluorometer (Fluoroskan; Thermo Fisher Scientific, Waltham, MA, USA) at 527 nm using an excitation wavelength of 485. For all measurements, basal fluorescence was subtracted.
All graphs, EC 50 and CC 50 values were produced using Graph Pad Prism 7 Software (GraphPad Software, Inc., La Jolla, CA, USA).
Docking Studies-Pre-Docking Preparation
The structure of trypanothione reductase bound to Flavin adenine dinucleotide (PDB ID: 2JK6) [46] were obtained from the Protein Data Bank. The Protein Preparation Wizard in Maestro was used to minimize the protein structure, add hydrogens and charges, and find any missing residues. The two-dimensional structures of 5D and Quinacrine Mustard, a recently experimentally approved drug as a control, were drawn using the molecular structure editor ChemDraw Software (PerkinElmer, Waltham, MA, USA) and processed by LigPrep Schrödinger (Schrödinger, LLC., New York, NY, USA) to generate the 3D structures.
Binding Site Analysis
Maestro's SiteMap tool (Schrödinger, LLC., New York, NY, USA) was used to predict the likely binding sites of trypanothione reductase. The SiteMap tool uses a series of algorithm that generates a map of hydrophobic and hydrophilic surfaces on the protein surface [47] . Hydrophilic surface maps are divided into donor, acceptor, and metal-binding regions. Five potential binding sites were identified with at least 15 site points. However, the top SiteMap was chosen to be the receptor grid. 
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